CONFERENCES

      BioIT World Conference

      This is an annual conference that explores the latest developments in biotechnology research, with topics ranging from gene editing to synthetic biology. The conference is aimed at researchers, industry professionals, and policymakers involved in the development and application of biotechnology, and provides a forum for sharing knowledge and collaborating on new approaches to solving global challenges.

      Bio-IT World Conference & Expo Europe 2023

      Date

      Nov 29, 2023 - Nov 30, 2023

      Location

      London, U.K.

      The 2nd Annual Bio-IT World Conference & Expo Europe offers the community to explore the intersection of IT and life sciences. This year's event program includes the keynotes, presentations, and discussions on digitalizing pharmaceutical research and development, using AI for drug discovery, storage infrastructure and cloud computing, efficient data management, and bioinformatics for real-world evidence solutions for disease prevention, prognosis, diagnostics, and therapeutics.

      15th Bio-IT World Conference & Expo 2016

      Date

      Apr 05, 2016 - Apr 07, 2016

      Location

      Boston, USA

      With more than 3,300 attendees from 41 countries, this conference includes over 200 technology and scientific presentations as well as 16 workshops.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.